Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04748354
Other study ID # H19-03812
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date May 3, 2021
Est. completion date May 31, 2024

Study information

Verified date April 2024
Source University of British Columbia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hip fracture is recognized as one of the most serious consequences of osteoporosis, less than half regain pre-fracture independence. 95% of all hip fractures in older adults are due to falls. Thus, reducing fall risk while restoring function post-hip fracture is critical. Many with fall-related hip fractures have cognitive impairment; cognitive impairment increases the risk of falls. The purpose of this 6-month proof-of-concept randomized controlled trial (RCT) is to assess the efficacy of the home-based Otago Exercise Program (OEP) compared with usual care in reducing fall risk among older adults with mild cognitive impairment (MCI) and a fall-related hip fracture.


Description:

Hip fracture is recognized as one of the most serious consequences of osteoporosis, less than half regain pre-fracture independence. 95% of all hip fractures in older adults are due to falls. Thus, reducing fall risk while restoring function post-hip fracture is critical. Many with fall-related hip fractures have cognitive impairment and they are less likely to regain pre-fracture level of function than those without cognitive impairment. Cognitive impairment also increase falls risk. It is currently unknown whether exercise is efficacious in reducing fall risk and promoting function among older adults with mild cognitive impairment (MCI) and a fall-related hip fracture. The purpose of this 6-month proof-of-concept RCT is to assess the efficacy of the home-based Otago Exercise Program (OEP) compared with usual care in reducing fall risk among community-dwelling older adults with MCI and a fall-related hip fracture.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date May 31, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: 1) aged 65 or older; 2) sustained a fall-related hip fracture in the last 12 months and have returned home; 3) have preserved general cognition as indicated by a Mini-Mental State Examination (MMSE) score = or > 20/30; 4) have subjective memory complaints, determined by interview;22 5) score < 26/30 on the Montreal Cognitive Assessment (MoCA); 6) have an absence of significant functional impairment and no dementia as determined by a physician; 7) are not expected to start, or are stable (i.e., > 3 months) on a fixed dose of anti-dementia medications (e.g., donepezil, galantamine) during the RCT; 8) are expected to live > 12 months (based on the geriatricians' expert opinion); 9) can read, write, and speak English with acceptable visual and auditory acuity; 10) are able to walk 3 meters with or without an assistive device; and 1) provide written informed consent. Exclusion Criteria: 1) diagnosed with or suspected to have (by the geriatrician) a neurodegenerative disease (e.g., Parkinson's disease) or dementia; 2) had a clinical stroke; or 3) have a history indicative of carotid sinus sensitivity (i.e., syncopal falls).

Study Design


Intervention

Behavioral:
Otago Exercise Program
An individualized and home-based program of progressive strength and balance training exercises delivered by a physical therapist
Other:
Usual Care
Clinical care provided by a geriatrician.

Locations

Country Name City State
Canada University of British Columbia Vancouver British Columbia

Sponsors (2)

Lead Sponsor Collaborator
University of British Columbia Amgen

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Physiological Profile Assessment A measure of fall risk (z-score). Baseline to 6 Months
Secondary Change in Short Physical Performance Battery A measure of balance and mobility (out of 12 points). Baseline to 3 Months and 6 Months
Secondary Change in Usual Gait Speed Gait speed over 4 meters (m/s). Baseline to 3 Months and 6 Months
Secondary Change in Life Space Assessment Mobility within a life-space level. Baseline to 3 Months and 6 Months
Secondary Change in NIH Cognitive Toolbox Cognitive performance of executive functions. Baseline to 3 Months and 6 Months
Secondary Change in Digit Symbol Substitute Test Cognitive performance of processing speed. Baseline to 3 Months and 6 Months
Secondary Change in Center for Epidemiological Studies Depression Scale Mood Baseline to 3 Months and 6 Months
Secondary Change in Positive and Negative Affect Scale Mood Baseline to 3 Months and 6 Months
Secondary Change in EQ-5D-5L Quality of Life Baseline to 3 Months and 6 Months
Secondary Change in ICE-CAP Wellbeing Baseline to 3 Months and 6 Months
Secondary Change in Physical Activity for the Elderly Physical activity over the last 7 days Monthly from Baseline to 6 Months
Secondary Total Number of Prospective Falls Self-report of falls using calendars Monthly from Baseline to 6 Months
Secondary Change in Activities Specific Balance Confidence Fall-related self efficacy Baseline to 3 Months and 6 Months
Secondary Change in Physiological Profile Assessment A measure of fall risk (z-score); higher z scores indicate higher risk of falls. Baseline to 3 Months
Secondary Change in Timed Up and Go Test A measure of functional mobility; greater time for completion indicate poorer performance. Baseline to 3 Months and 6 Months
Secondary Change in Fried Frailty A measure of physical frailty Baseline to 3 Months and 6 Months
Secondary Change in Pittsburgh Sleep Quality Index A measure of subjective sleep quality Baseline to 3 Month and 6 Months
Secondary Change in Rey Auditory Verbal Learning A measure of episodic memory; higher scores indicate bettter episodic performance. Baseline to 3 Month and 6 Months
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A